Criteria for creating and assessing mouse models of diabetic neuropathy.
about
Animal models of peripheral neuropathiesDiabetic neuropathy: mechanisms to managementDiabetes regulates mitochondrial biogenesis and fission in mouse neurons.Leptin- and leptin receptor-deficient rodent models: relevance for human type 2 diabetes.The effects of anesthesia on measures of nerve conduction velocity in male C57Bl6/J mice.The use of animal models in diabetes research.Mechanisms of disease: the oxidative stress theory of diabetic neuropathyPrevention of diabetic neuropathy by regulatable expression of HSV-mediated erythropoietin.Hyperglycemia- and neuropathy-induced changes in mitochondria within sensory nerves.Cortical neurons develop insulin resistance and blunted Akt signaling: a potential mechanism contributing to enhanced ischemic injury in diabetes.Transcriptional profiling of diabetic neuropathy in the BKS db/db mouse: a model of type 2 diabetes.Hyperinsulinemia induces insulin resistance in dorsal root ganglion neuronsBTBR ob/ob mice as a novel diabetic neuropathy model: Neurological characterization and gene expression analysesBeneficial effects of levobupivacaine regional anaesthesia on postoperative opioid induced hyperalgesia in diabetic mice.Gender-specific differences in diabetic neuropathy in BTBR ob/ob miceApolipoprotein E knockout as the basis for mouse models of dyslipidemia-induced neuropathy.NON-INVASIVE EVALUATION OF NERVE CONDUCTION IN SMALL DIAMETER FIBERS IN THE RAT.Animal models of diabetic neuropathy: progress since 1960s.An overview of animal models of pain: disease models and outcome measures.Dyslipidemia-induced neuropathy in mice: the role of oxLDL/LOX-1.Neuropathic pain: a maladaptive response of the nervous system to damage.Chewing the fat: genetic approaches to model dyslipidemia-induced diabetic neuropathy in miceExperimental induction of type 2 diabetes in aging-accelerated mice triggered Alzheimer-like pathology and memory deficitsMouse models of diabetic neuropathy.Rodent models of chemotherapy-induced peripheral neuropathy.Beneficial effects of a novel RAGE inhibitor on early diabetic retinopathy and tactile allodynia.Removing the cloak of invisibility: phenotyping the mouse.Tracking Epidermal Nerve Fiber Changes in Asian Macaques: Tools and Techniques for Quantitative Assessment.Mitochondrial biogenesis and fission in axons in cell culture and animal models of diabetic neuropathy.Soluble epoxide hydrolase inhibition alleviates neuropathy in Akita (Ins2 Akita) mice.Elevated Expression of Carboxy-Terminal Modulator Protein (CTMP) Aggravates Brain Ischemic Injury in Diabetic db/db Mice.Comparative study of peripheral neuropathy and nerve regeneration in NOD and ICR diabetic mice.Intravitreal pro-inflammatory cytokines in non-obese diabetic mice: Modelling signs of diabetic retinopathy
P2860
Q27028046-720E283D-CCDE-4E97-8138-A50BC29B0277Q33554384-6EF97AA5-410F-429D-910E-0A82B4A33A5FQ33571558-7AD3F9D2-47A0-4975-A7B2-31AB4F67FD8AQ33846858-786E859C-6703-43B3-AB1E-11AA393DF652Q34135732-DD769165-AADA-4DBB-BD79-A3A28C5F15D7Q34255921-B7765981-5D80-41F4-83B9-7C95C8CE3A0AQ34553052-99516CF6-C8ED-426C-B45C-2BE8C100E998Q34556841-C8C8730F-5673-42D2-8140-9738736DA15FQ34562861-DAF9BC70-2325-4189-9C84-1801AF10D4ABQ34805939-1BC70F7E-A46D-428A-8093-0781DAAA9291Q35063229-9C6EF464-48A9-4A29-9572-4CB50EC00825Q35223053-4E4600A7-4E18-4573-AC11-DE4FC8A5A9E7Q35558662-A548C965-B611-4B1A-8F9C-429ECDFECDE3Q35806909-3FC0FE7C-FCB2-4091-9BC4-64337AEEB725Q36421364-4CE53199-DBD7-4AF6-8E2C-63031B12CE05Q36501212-4CCFFD2F-7EFD-4535-A71B-B5BEE94D2D36Q36750823-F02A3734-6B9D-41F4-9F1C-E0A837DB818EQ37100970-C65CB373-464D-41A9-A42B-1ACD0FE972BDQ37282107-B6BABAE1-AAD7-42CC-85A5-D5E0782C7994Q37360464-8AC90BB2-2DB0-4F4C-9F76-CEEC64B6288FQ37401775-161296CB-B664-477C-84E6-6CCC1369307DQ37572538-5315EF75-27F6-487B-BCE9-5A8E690DAAA0Q37615991-E4228400-0CD4-4B4E-8231-BF6E15564F85Q37655239-87C51E41-F657-47D4-AAA3-A1060B05BC6CQ38194947-67CD605D-6951-4E20-AB9B-592DD61A280BQ39727356-8510A250-F50E-4BDF-AEA1-A71E98F9DF73Q40022642-E66BB9FC-9998-43E9-B1D1-FFE61B8BC626Q40655635-531862ED-BEED-469F-96C4-397A5EFF95FAQ42003724-9C0D4FB9-6E04-4092-BD84-EB8EF6600495Q46614540-65F1EAFA-BF36-4CB4-9486-E50355B18EF1Q48752394-7DE097A7-C388-465D-9FBF-5CDED92207F0Q51000222-57814EC8-A630-49E9-AE4B-FF7255D5F776Q58723006-1BB35031-2E00-44C0-9853-2E72B8694949
P2860
Criteria for creating and assessing mouse models of diabetic neuropathy.
description
2008 nî lūn-bûn
@nan
2008 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Criteria for creating and assessing mouse models of diabetic neuropathy.
@ast
Criteria for creating and assessing mouse models of diabetic neuropathy.
@en
type
label
Criteria for creating and assessing mouse models of diabetic neuropathy.
@ast
Criteria for creating and assessing mouse models of diabetic neuropathy.
@en
prefLabel
Criteria for creating and assessing mouse models of diabetic neuropathy.
@ast
Criteria for creating and assessing mouse models of diabetic neuropathy.
@en
P2093
P2860
P1433
P1476
Criteria for creating and assessing mouse models of diabetic neuropathy.
@en
P2093
Eva L Feldman
John L Roberts
Kelli A Sullivan
Stephen I Lentz
P2860
P356
10.2174/138945008783431763
P577
2008-01-01T00:00:00Z